Vaccines: Spinning molecular immunology into successful immunotherapy

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature reviews. Immunology

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nri774PMID 12001994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)

  2007cited by this paper
• Roles of heat-shock proteins in innate and adaptive immunity

  2002cited by this paper
• Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.

  2001cited by this paper
• Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis.

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein.

  2001cited by this paper
• B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

  2001cited by this paper
• Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.

  2001cited by this paper
• Negative regulation of cytokine signaling

  2001cited by this paper
• Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.

  2001cited by this paper
• Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes.

  2001cited by this paper
• Toll-like receptors: critical proteins linking innate and acquired immunity

  2001cited by this paper
• The role of heat shock protein (hsp70) in dendritic cell maturation: Hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors

  2001cited by this paper
• CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

  2001cited by this paper
• Improving Vaccine Potency Through Intercellular Spreading and Enhanced MHC Class I Presentation of Antigen1

  2001cited by this paper
• Virus subversion of immunity: a structural perspective.

  2001cited by this paper
• Signaling through OX40 (CD134) breaks peripheral T-cell tolerance

  2001cited by this paper
• Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (alvac) cytokine gene delivery induces destruction of established prostate tumors

  2001cited by this paper
• Equipotent Generation of Protective Antitumor Immunity by Various Methods of Dendritic Cell Loading With Whole Cell Tumor Antigens

  2001cited by this paper
• CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

  2001cited by this paper
• Recombinant BCG vaccines.

  2001cited by this paper
• Activation of the Cooh-Terminal Src Kinase (Csk) by Camp-Dependent Protein Kinase Inhibits Signaling through the T Cell Receptor

  2001cited by this paper
• CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling

  2001cited by this paper
• Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.

  2001cited by this paper
• Targeting dendritic cells to enhance DNA vaccine potency.

  2001cited by this paper
• Characterization of Heat Shock Protein 110 and Glucose-Regulated Protein 170 as Cancer Vaccines and the Effect of Fever-Range Hyperthermia on Vaccine Activity1

  2001cited by this paper
• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  2000cited by this paper
• HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine

  2000cited by this paper
• The prime-boost strategy: exciting prospects for improved vaccination.

  2000cited by this paper
• Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity1

  2000cited by this paper
• The T-cell protein tyrosine phosphatase.

  2000cited by this paper
• Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.

  2000cited by this paper
• Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b

  2000cited by this paper
• Recent advances with recombinant bacterial vaccine vectors.

  2000cited by this paper
• Recent advances with recombinant bacterial vaccine

  2000cited by this paper
• Cbl-b regulates the CD28 dependence of T-cell activation

  2000cited by this paper
• Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways

  2000cited by this paper
• Live bacterial delivery systems for development of mucosal vaccines.

  2000cited by this paper
• Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines

  2000cited by this paper
• Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.

  2000cited by this paper
• Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

  2000cited by this paper
• Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.

  2000cited by this paper
• The Dendritic Cell Receptor for Endocytosis, Dec-205, Can Recycle and Enhance Antigen Presentation via Major Histocompatibility Complex Class II–Positive Lysosomal Compartments

  2000cited by this paper
• Targeting Human Papillomavirus Type 16 E7 to the Endosomal/Lysosomal Compartment Enhances the Antitumor Immunity of DNA Vaccines against Murine Human Papillomavirus Type 16 E7-Expressing Tumors

  1999cited by this paper
• Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm.

  1999cited by this paper
• High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.

  1999cited by this paper
• Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

  1999cited by this paper
• Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response

  1999cited by this paper
• CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.

  1999cited by this paper
• Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

  1999cited by this paper
• B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

  1999cited by this paper
• Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

  1998cited by this paper
• The Central Role of CD4+ T Cells in the Antitumor Immune Response

  1998cited by this paper
• Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes.

  1998cited by this paper
• CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

  1998cited by this paper
• Immunocytokines: a promising approach to cancer immunotherapy.

  1998cited by this paper
• Heteroclitic Immunization Induces Tumor Immunity

  1998cited by this paper
• B cells inhibit induction of T cell-dependent tumor immunity

  1998cited by this paper
• Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.

  1997cited by this paper
• Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy

  1997cited by this paper
• Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

  1997cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1997cited by this paper
• Developmental regulation of MHC class II transport in mouse dendritic cells

  1997cited by this paper
• Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

  1997cited by this paper
• Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.

  1997cited by this paper
• Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy

  1997cited by this paper
• SSX: A multigene family with several members transcribed in normal testis and human cancer

  1997cited by this paper
• Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

  1997cited by this paper
• Cancer Tumor antigens.

  1997cited by this paper
• Oral somatic transgene vaccination using attenuated S. typhimurium.

  1997cited by this paper
• Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

  1997cited by this paper
• Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

  1997cited by this paper
• Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.

  1997cited by this paper
• Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors.

  1997cited by this paper
• Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.

  1997cited by this paper
• A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells.

  1997cited by this paper
• Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases

  1997cited by this paper
• Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases

  1997cited by this paper
• Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

  1997cited by this paper
• Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma

  1996cited by this paper
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

  1996cited by this paper
• Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

  1996cited by this paper
• Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

  1996cited by this paper
• Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

  1996cited by this paper
• Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

  1996cited by this paper
• Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

  1996cited by this paper
• Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.

  1996cited by this paper
• Human tumor antigens recognized by T cells.

  1996cited by this paper
• Human CD14+ leukocytes acquire the phenotype and function of antigen‐presenting dendritic cells when cultured in GM‐CSF and IL‐4

  1996cited by this paper
• Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.

  1996cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

  1996cited by this paper
• Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.

  1996cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1996cited by this paper
• Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

  1996cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper

• Response efficacy of PD-1 and PD-L1 inhibitors in salivary gland cancers: a systematic review and meta-analysis

  2025cites this paper
• Amphipathic Alpha-Helical Peptides AH1 and AH3 Facilitate Immunogenicity of Enhanced Green Fluorescence Protein in Rainbow Trout (Oncorhynchus mykiss)

  2025cites this paper
• TIPE2 inhibits melanoma progression through MEK/ERK signaling

  2024cites this paper
• Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review

  2022cites this paper
• Corosolic Acid Inhibits Secretory Phospholipase A2IIa as an Anti-Inflammatory Function and Exhibits Anti-Tumor Activity in Ehrlich Ascites Carcinoma Bearing Mice

  2022cites this paper
• Efficacy of bivalent CEACAM6/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice

  2022cites this paper
• Studies in lung cancer cytokine proteomics: a review

  2021cites this paper
• Nanomedicines in B Cell-Targeting Therapies.

  2021cites this paper
• Engineering Nano-Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment.

  2021cites this paper
• Preoperative Fibrinogen and Hematological Indexes in the Differential Diagnosis of Idiopathic Granulomatous Mastitis and Breast Cancer

  2021cites this paper
• Significant Effects of CCR5delta32 Polymorphism on Alzheimer‘S Disease, Neurological Disorders, Cancer, Diabetes and Viral Infection in the Worldwide Population

  2021cites this paper
• Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma

  2021cites this paper
• Reduction-Sensitive Protein Nanogels Enhance Uptake of Model and Tumor Lysate Antigens In Vitro by Mouse- and Human-Derived Dendritic Cells.

  2021cites this paper
• Protective CD8+ T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/Kb transgenic mice

  2020cites this paper
• The role and clinical significance of programmed cell death- ligand 1 expressed on CD19+B-cells and subsets in systemic lupus erythematosus.

  2019cites this paper
• Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine

  2019cites this paper
• Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.

  2019cites this paper
• Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer

  2019cites this paper
• Chronic prostatitis/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines

  2019cites this paper
• PD-L1 expression in malignant salivary gland tumors

  2018cites this paper
• Modelling of Experimental Infections

  2018cites this paper
• Modulating T-cell-based cancer immunotherapy via particulate systems

  2018cites this paper
• Overexpression of PD-l 2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

  2017cites this paper
• Design of nanoparticle structures for cancer immunotherapy

  2017cites this paper
• Inmunoterapia del cáncer 2002

  2017cites this paper
• Dendritic cells based immunotherapy.

  2017cites this paper
• The effect of feed supplementation with Zakarpacki zeolite (clinoptilolite) on percentages of T and B lymphocytes and cytokine concentrations in poultry

  2017cites this paper
• Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against Tumor

  2017cites this paper
• Whole-cell vaccines

  2017cites this paper
• Development and Optimization of Peptide-Based, Tumor-Associated Macrophage (TAM)-Targeting Therapeutics

  2017influential citation
• Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

  2017cites this paper
• Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy.

  2017cites this paper
• THE ROLE OF THE IL-17/IL-17R AXIS IN BREAST TUMOR GROWTH AND METASTASIS

  2016cites this paper
• Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.

  2016cites this paper
• New Treatments and New Therapies

  2016cites this paper
• Designing and modeling of complex DNA vaccine based on MOMP of Chlamydia trachomatis: an in silico approach

  2016cites this paper
• Synthesis and evaluation of multivalent M 2 pep peptides for targeting alternatively activated M 2 macrophages

  2016cites this paper
• Polymer-Based DNA Delivery Systems for Cancer Immunotherapy

  2016cites this paper
• Chimeric antigen receptor (CAR) T cell therapy for malignant cancers: Summary and perspective

  2016cites this paper
• The cell cycle inhibitor Cdkn1a regulates Langerhans cell radiation resistance and promotes T regulatory cell generation upon exposure to ionizing irradiation

  2015cites this paper
• Adjuvant Immunotherapy for Cancer: From Basic Research to Clinical Bench

  2015cites this paper
• CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation

  2015cites this paper
• Marked anti-tumor effects of CD8+CD62L+ T cells from melanoma-bearing mice

  2015cites this paper
• Inflammation and Lung Cancer

  2015cites this paper
• Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• Transgenic Eimeria mitis expressing chicken interleukin 2 stimulated higher cellular immune response in chickens compared with the wild-type parasites

  2015cites this paper
• Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors.

  2015cites this paper
• The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions

  2015cites this paper
• Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance

  2015cites this paper
• Recombinant Lipoproteins as Novel Vaccines with Intrinsic Adjuvant.

  2015cites this paper
• Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells

  2015cites this paper
• Emerging Strategies for Cancer Immunoprevention

  2015cites this paper
• Inflammation and Lung Cancer: Addressing Inflammation with Immunotherapy

  2015cites this paper
• Unconventional Computation and Natural Computation

  2014influential citation
• CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects.

  2014cites this paper
• Immunologic Approaches to Lung Cancer Therapy

  2014cites this paper
• What Is the Future of Immunotherapy in Ovarian Cancer

  2014cites this paper
• Enhancing The Efficacy Of DNA Vaccines

  2014cites this paper
• Allogeneic tumor cell vaccines

  2014cites this paper
• Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy

  2014cites this paper
• Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells.

  2014cites this paper
• Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity

  2014cites this paper
• A novel multi-epitope peptide vaccine against cancer: an in silico approach.

  2014cites this paper
• Steps toward Developing an Artificial Cell Signaling Model Applied to Distributed Fault Detection

  2014cites this paper
• A carbon nanotube-polymer composite for T-cell therapy.

  2014cites this paper
• The direct display of costimulatory proteins on tumor cells as a means of vaccination for cancer immunotherapy.

  2014cites this paper
• Interleukin-17 and type 17 helper T cells in cancer management and research

  2014cites this paper
• Die Lokalisation von PD-1 während des "Kiss of Death"

  2014cites this paper
• Engaging adaptive immunity with biomaterials.

  2014cites this paper
• Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival

  2013cites this paper
• Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

  2013cites this paper
• Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

  2013cites this paper
• HER2/neu-specific Breast Cancer Vaccine

  2013cites this paper
• Ex vivo imaging immune cell interactions in T cell vaccine-induced immunity and CD8+CD25+ T regulatory cell-mediated immune suppression

  2013influential citation
• Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III.

  2013cites this paper
• MS-275 (ENTINOSTAT) PROMOTES SUSTAINED TUMOR REGRESSION IN THE CONTEXT OF BOOSTING ONCOLYTIC IMMUNOTHERAPY

  2013cites this paper
• Allogeneic Corneal Graft Survival T Cells , and Prolongs + Increases Foxp 3 IDO-Mediated Immune Modulation , Topical Application of Soluble CD 83 Induces

  2013cites this paper
• Breaking T-cell tolerance in chronic lymphocytic leukaemia

  2013cites this paper
• Vaccine and Cancer Therapy for Genitourinary Tumors

  2012cites this paper
• Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment.

  2012cites this paper
• Incomplete tumour control following DNA vaccination against rat gliomas expressing a model antigen

  2012cites this paper
• Diffusive transfer between two intensely interacting cells with limited surface kinetics.

  2012cites this paper
• THE CRITICAL ROLE OF CD4+ TH CELLS IN CD8+ CTL RESPONSES AND ANTI-TUMOR IMMUNITY

  2012cites this paper
• Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells.

  2012cites this paper
• Prophylactic vaccine approach for colon and pancreatic cancers: present and future.

  2012cites this paper
• Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens.

  2012cites this paper
• Immunotherapy in clinical medicine: historical perspective and current status.

  2012cites this paper
• Phytochemical and Pharmacological Investigation on Tephrosia Purpurea,Ficus Glomerata, Ficus Religiosa in Animal Models.

  2012cites this paper
• Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues

  2012cites this paper
• Major virulence factors of enterotoxigenic Escherichia coli in pigs

  2012cites this paper
• tolerance after stem cell transplantation Induction of type I IFN is required for overcoming tumor-specific T-cell

  2012cites this paper
• Multivalent Porous Silicon Nanoparticles Enhance the Immune Activation Potency of Agonistic CD40 Antibody

  2012cites this paper
• Cancer genomics: technology, discovery, and translation.

  2012cites this paper
• A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling

  2012cites this paper
• An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response*

  2011cites this paper
• Development of tools to target antigen through mannose receptor

  2011cites this paper
• Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens

  2011cites this paper
• Stimulation of B7-H3 (CD276) directs the differentiation of human marrow stromal cells to osteoblasts.

  2011cites this paper
• Adenosine receptors and cancer.

  2011cites this paper